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ABSTRACT IN MALAY 
Latarbelakang: 
Goiter besar merupakan satu masalah yang lazim ditemui dan dirawati oleh pakar bedah 
endokrin di negara membangun tetapi isu mengenai goiter besar jarang dibincangkan, 
terutamanya isu mengenai kaitan di antara goiter besar dan kanser tiroid. Objektif kajian 
ini ialah untuk menganalisa faktor-faktor yang berkaitan untuk kanser tiroid dalam goiter 
besar dan juga komplikasi pembedahan ke atas goiter besar.  
Kaedah:  
Rekod pesakit yang menjalani pembedahan primari tiroid dari Jun 2007 sehingga Mei 
2013 dikaji. Pesakit akan dijadikan subjek kajian jika berat spesimen kelenjar tiroid 
daripada pembedahan ‘hemithyroidectomy’ ≥50g atau pembedahan ‘total thyroidectomy’ 
≥100g. Factor yang berkaitan dengan kanser tiroid dalam goiter besar (umur, jantina, status 
fungsi tiroid, tanda-tanda tekanan oleh goiter dan ‘nodularity’) dikaji. Komplikasi 
pembedahan tiroid seperti ‘hypoparathyroidism’ sementara dan kekal, kecederaan ‘RLN’, 
pendarahan, infeksi pada luka kawasan bedah, kecederaan organ sekeliling dan kematian 
akan direkodkan.  
Keputusan kajian:  
Sebanyak 611 pesakit yang menjalani pembedahan tiroid dijadikan subjek dalam kajian ini. 
Kelaziman tiroid besar adalah 410 (67.1%) dan kelaziman kanser tiroid diantara goiter 
besar adalah 115 (28.0%). Pesakit dengan goiter besar mempunyai peluang yang lebih 
tinggi untuk menghidapi kanser tiroid dengan nisbah ganjil 1.52 (1.02, 2.28). Analisa 
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Logistik Regrasi Pelbagai menunjukkan bahawa peningkatan umur dan ‘solitary thyroid 
nodule (STN)’ merupakan factor-faktor yang mempunyai peluang yang lebih tinggi untuk 
menghidapi kanser tiroid dalam goiter besar, masing-masing dengan nisbah ganjil 1.02 
(1.01, 1.04) dan 1.80 (1.10, 2.94). Seramai 82 (25.5%) mengalami ‘hypoparathyroidism’ 
sementara, 9 (2.8%) ‘hypoparathyroidism’ kekal, 4 (1.2%) kecederaan ‘recurrent laryngeal 
nerve (RLN)’, 8 (2.5%) pendarahan, 6 (1.8%) infeksi pada luka kawasan bedah, 4 (1.2%) 
kecederaan organ sekeliling dan 1 (0.3%) kematian.  
Kesimpulan:  
Kelaziman goiter besar yang tinggi di negara membangun memerlukan cara rawatan 
penyakit tiroid yang berbeza. Goiter besar adalah lebih lazim berkaitan dengan kanser 
tiroid. Disebabkan oleh keraguan mengenai sensitiviti ‘fine needle aspiration cytology 
(FNAC)’ untuk mengesahkan kanser tiroid dalam goiter besar, kita sepatutnya 
mempertimbangkan pembedahan lebih awal, terutamanya pesakit tua dan ‘STN’. 
Bagaimanapun, risiko pembedahan untuk goiter besar sepatutnya dipertimbangkan dan 
pembedahan ini sepatutnya hanya dilakukan oleh pakar dalam bidang ini.   
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ABSTRACT IN ENGLISH  
Background:  
Large goiters are very common and it is frequently encountered by endocrine surgeons 
especially in developing countries. Rarely, issues regarding large goiters have been 
discussed, particularly the association between large goiter and thyroid cancers. The 
objectives of this study are to analyze the associate factors of thyroid malignancy in large 
goiters as well as the surgical complications in performing resection for large goiters. 
Methods:  
Patients who had primary thyroid surgery between June 2007 and May 2013 were 
retrospectively reviewed. Patients who underwent thyroidectomy with a resected specimen 
of ≥ 50g in hemithyroidectomy or ≥ 100g in total thyroidectomy were recruited in the 
study. The associate factors for thyroid cancer in large goiters (age, gender, thyroid 
function status, compression symptom and, nodularity) were analyzed. The surgical 
complications namely temporary hypocalcaemia, permanent hypoparathyroidism, RLN 
injury, post-operative haemorrhage, surgical site infection, local structures injury and 
mortality associated with thyroid surgery were recorded.  
Results:  
A total of 611 patients who had capsular dissection thyroid surgeries were recruited in the 
study. The prevalence of large goiter was 410 (67.1%) and the prevalence of thyroid 
malignancy in large goiters was 115 (28.0%). The patients with large goiters had higher 
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chance to have thyroid malignancies with OR of 1.52 (1.02, 2.28). Multiple Logistic 
Regression Analysis revealed that the significant associate factors for thyroid malignancy 
in large goiters were age and STN with OR of 1.02 (1.01, 1.04) and 1.80 (1.10, 2.94), 
respectively. There were 82 (25.5%) temporary hypocalcaemia, 9 (2.8%) permanent 
hypoparathyroidism, 4 (1.2%) RLN injuries, 8 (2.5%) post-operative haemorrhages, 4 
(1.2%) local structure injuries and 1 (0.3%) death after thyroid surgery for large goiters.  
Conclusions:  
The high prevalence of large goiters in the developing countries necessitates the different 
approach in the management of thyroid disease. Large goiters are associated with higher 
prevalence for thyroid malignancy. With the doubt of sensitivity in detecting thyroid 
malignancy from FNAC in large goiter, surgeons should consider removing the goiter 
early especially in older patients and those with STN. Nevertheless, the risks of surgery for 
large goiter should be deliberated and the surgery should only be performed by expert 
personal. 
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CHAPTER 1: INTRODUCTION   
A goiter is defined as an enlargement of the thyroid gland. It is derived from the French 
(goiter) and Latin (guttur), which both mean throat. It is a very common clinical problem. 
At least 4% of population in iodine-sufficient countries has palpable goiters and about 50% 
can be detected by using ultrasonography (Polyzos et al., 2007). The disease often progress 
in time with the increase in size of the thyroid gland. However, the natural history of 
thyroid growth varies from patient to patient. It is very difficult to predict and monitor the 
growth of the thyroid gland. Furthermore, there is always a concern of the possibility that 
the goiter may harbour occult malignancy (Costamagna et al., 2013; Miccoli et al., 2006). 
Goiters can be classified into toxic or non-toxic, endemic or non-endemic, diffuse 
or nodular. Nodular goiters are further classified into solitary thyroid nodule (STN) and 
multinodular goiter (MNG). Goiter is considered endemic when it involves more than 10% 
of the population. Iodine deficiency is the cause of endemic goiter especially in the 
developing countries. Sporadic or non-endemic goiters have the prevalence of 4-7% which 
the cause remains unclear and it is most probably multifactorial involving genetic and 
environmental factors (Daniels, 1996). 
Thyroid malignancy is relatively rare compared to epithelial malignancy and it 
represents 1% of all human neoplasm (Curado, 2008). Although rare, thyroid malignancy 
remains the most frequent form of malignancy of endocrine glands.  The incidence of 
thyroid cancer has increased for the past few decades in several developed countries 
(Burgess, 2002; Colonna et al., 2002; Davies and Welch, 2014; Hodgson et al., 2004). 
Many experts believe that the increased incidence of thyroid cancer is resulted primarily 
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from the availability of the more sensitive diagnostic procedures which increase the 
detection of small cancers in the preclinical stage. This is evidenced by the rise of the 
numbers of incidentalomas. Some suggested that the increased incidence is most likely due 
to a combination of an apparent increase due to higher detection rates and of a true increase, 
a possible consequence of increased population exposure to radiation and to other 
unrecognized carcinogens (Pellegriti et al., 2013). 
Many studies have been conducted to identify the risk factors for thyroid 
malignancy but the results obtained vary. In a study by Rios er al. reported that family 
history of thyroid pathology, personal history of cervical radiation therapy, prior surgery, 
and presence of cervical lymphadenopathies on physical exploration were the risk factors 
of thyroid malignancy (Rios et al., 2004). Other associated risks for thyroid cancer include 
male gender, younger age, fewer  nodules and smaller nodule size have also been reported 
(Luo et al., 2012). A population-based study in Korea found that older age, female, 
overweight, higher monthly household income, higher educational level, and alcohol 
consumption were significant risk factors for thyroid cancer (Choi et al., 2013). 
Previously it was thought that MNG carries lower risk of malignancy as compared 
to STN. But recent studies showed the trend towards similar risk for malignancy and the 
incidence of malignancy in MNG should not be underestimated (Gandolfi et al., 2004; 
Pradhan et al., 2011; Sachmechi et al., 2000). Traditionally, hyperthyroidism was once 
viewed as a protective factor for thyroid malignancy. In the year 1954, Sokal et al. showed 
that patients with hyperthyroidism had a higher incidence of thyroid carcinoma (Sokal, 
1954). Since then, association between hyperthyroidism and thyroid malignancy had 
drawn a particular attention over the decades. Recent studies showed that a higher risk of 
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malignancy in patients with hyperthyroidism as compared to euthyroidism (Karagulle et al., 
2009; Negro et al., 2013; Smith et al., 2013).  
There are only a few studies regarding large goiters. This is most probably due to 
lack of study subjects in non-endemic, developed countries (Heck et al., 2007; Phitayakorn 
et al., 2006). So far, there is no study regarding the prevalence and risk of malignancy in 
large goiters. Hence, lack of evidence-based study to suggest an optimal diagnostic tool 
and the role of surgery may potentially lead to mis-management of patients with large 
goiter. Large goiter is not an indication for surgery unless patient presented with pressure 
symptom, malignant disease or cosmetic issues (Gharib et al., 2010). If large goiter is 
associated with thyroid cancer, this will alters our management in term of early surgical 
intervention, biopsy before the surgery and lastly, to subject patients for medical or 
radioiodine therapy which will delay the management of underlying malignant disease. 
Ultrasonography (US) and fine needle aspiration cytology (FNAC) are routine pre-
operative investigations for nodular goiter. Studies of US to detect malignancy in goiter 
show 20% rates of false negative and it is suggested that US was not reliably to exclude 
malignancy in a large thyroid nodule (Wharry et al., 2013). Furthermore, FNAC in 
diagnosing thyroid malignancy has significant false negative rate ranged 5-50% especially 
in large goiter and in MNG (Akgul et al., 2011; McCoy et al., 2007; Pinchot et al., 2009). 
If pre-operative investigations are not reliable to detect malignancy in large goiter, 
thyroidectomy is the only option to ensure the accurate diagnosis. The selection of patient 
with large goiter for early surgical intervention will be much dependent on other associate 
risks for malignancy. The issues of whether all patients with large goiters need surgery and 
the extent of thyroidectomy in large goiter remain to be answered.  
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Studies for complications after thyroidectomy for large goiter are scarce (Agarwal 
et al., 2012; Gardiner and Russell, 1995). Both studies gave different rates of surgical 
complications in large goiters. Complications following thyroidectomy for large goiters are 
predicted to be more than thyroidectomy performed on small goiters. Safety is an issue to 
be considered when performing a thyroid surgery in large goiters. It shall be safe with 
minimum morbidity and mortality rate.     
In Malaysia, we have more number of patients with large goiters due to long 
standing disease before seeking medical attention. Management plans in term of indication 
for surgery, type of surgery and the need for biopsy and US before the surgery might be 
different from what is being practiced in other part of the world. To determine the optimal 
clinical management of large goiter, we retrospectively reviewed the records of all patients 
who underwent thyroidectomy in the years 2007 through 2013. Our goals were, first, to 
calculate the prevalence of large goiter in thyroidectomy patients; second, to evaluate the 
prevalence of malignancy in large goiter; and, third, to determine the likelihood associate 
factors of thyroid malignancy in large goiters. We would also like to know the rate of 
complication and surgical outcome following thyroidectomy in large goiters. Perhaps, this 
will guide us in our management for patients with large goiters in the future.    
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CHAPTER 2: OBJECTIVES  
To study the prevalence and the possible associated factors for thyroid malignancy in 
patients with large goiters. 
Specific objectives  
1. To determine the prevalence of large goiters among thyroidectomy patients. 
2. To determine the prevalence of thyroid malignancy in patients with large goiters. 
3. To determine the association between size of goiters and thyroid malignancy.  
4. To identify the associated factors (demographic and clinical) of thyroid malignancy 
in large goiters. 
5. To describe the proportion of the surgical outcome and complication rate following 
thyroidectomy for large goiters  
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Research Questions  
1. How prevalent is large goiter observed among thyroidectomy patients? 
2. How prevalent is thyroid malignancy observed in patients with large goiters? 
3. Is there any significant association between size of goiters and thyroid malignancy? 
4. Is there any significant association between demographic (age, gender) or clinical 
characteristics (nodularity, thyroid function status, pressure symptoms) and thyroid 
malignancy in large goiters? 
5. What is the rate of complication (temporary hypocalcaemia, permanent 
hypoparathyroidism, recurrent laryngeal nerve (RLN) injury, haemorrhage, surgical 
site infection (SSI), other organs injury and mortality) following thyroidectomy for 
large goiters? 
Research Hypothesis  
Hypothesis 1 
H0: Large goiter is not associated with thyroid malignancy. 
HA: Large goiter is associated with thyroid malignancy. 
Hypothesis 2 
H0: Age, gender, nodularity, thyroid function status and pressure symptoms are not 
associated with the risk of thyroid malignancy in large goiters. 
HA: Age, gender, nodularity, thyroid function status and pressure symptoms are associated 
with the risk of thyroid malignancy in large goiters. 
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CHAPTER 3: LITERATURES REVIEW   
3.1 Large goiter 
The weight of a normal thyroid gland is approximately 10 to 20 grams (Langer, 1999). A 
large goiter is defined as a resected specimen of more than or equal to 50g in 
hemithyroidectomy and more than or equal to 100g in total thyroidectomy. This defines a 
large goiter is at least five times greater than a normal thyroid gland. Review of the 
literatures unable to find the first author who describes the definition of large goiter. The 
earliest definition was made by Hamburger in 1985. The author defined large toxic MNGs 
as those having estimated weights of 100 g or more and massive goiters as those having 
weights 200g or more. The effect of radioiodine therapy in toxic MNG was studied by the 
author and the weight of the thyroid glands were estimated based on clinical palpation, 
thyroid imaging, or combinations of methods (Hamburger and Hamburger, 1985).   
 It is impossible to determine the exact weight of a thyroid gland before surgery. A 
literature review by Langer in 1999 stated that there are 3 ways to estimate the size of a 
thyroid gland: by post mortem thyroid weight, by palpation and, by ultrasound volumetry 
(Langer, 1999). Most of the endocrine surgeons prefer to estimate thyroid weight by 
palpation and this is entirely based on the experience with interpersonal bias. Ultrasound of 
thyroid had become famous for the past two to three decades. Estimation of thyroid glands 
volume can be done by using ultrasound. But the correlation between the volume and the 
weight is yet to be determined.   
Phitayakarn et al. conducted a study regarding large goiter in United States. In this 
study, potential epidemiological variables associated with the development of large 
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nodular goiter were investigated. In the study, the definition of unilateral large goiter was ≥ 
50g and bilateral large goiter was ≥ 100g. Our study used the same criteria to define 
unilateral and bilateral large goiters. According to the study, the incidence of large goiter 
among thyroidectomies patients was 23%. The factors associated with large goiter are 
African-American race (adjusted odds ratio 3.3, 95% CI = 2.0-5.4), obesity (adjusted odds 
ratio 2.5, 95% CI = 1.5-4.0) and age more than 40 years old (adjusted odds ratio 2.1, 95% 
CI = 1.2-3.8). Gender, family history, smoking and alcohol intake are not associated with 
higher risk of large goiter (Phitayakorn et al., 2006).  
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3.2 Thyroid Malignancy  
3.2.1  The incidence of thyroid cancer  
Thyroid cancer is uncommon and represents only 1% of all malignancies. In year 2002, a 
report of thyroid cancer incidence in Australia was published based on the data from 
Australia's regional cancer registries. There were 9,053 new cases of thyroid cancer in 
Australia for the period 1982-1997. Papillary, follicular, medullary, anaplastic, and "other 
diagnoses," accounted for 65.8%, 17.8%, 4.6%, 1.3%, and 10.5% of registered cases 
respectively (Burgess, 2002). In France, data collected between the periods of 1978-1997 
reported a total of 3853 adult cases of thyroid cancer. The incidence of thyroid cancer 
increased by 6.2% per year in men and by 8.1% per year in women (Colonna et al., 2002). 
Similar report of increasing incidence of thyroid cancer was shown in an analysis by 
Hodgson et al. in Florida, United States between 1990 and 2000. The age-adjusted 
incidence rates increased from 4.2 per 100,000 to 7 per 100,000 in 2000 with estimated 
annual percent change of 5.5% (P< 0.001) in this period (Hodgson et al., 2004). 
 Incidence of incidental cancer in patients operated for benign thyroid disease was in 
the increasing trend as reported by a study conducted by Costamagna et al. The study 
included a total of 568 patients underwent surgery for benign thyroid disease. Incidental 
cancer was found in 53 patients (9.3%) in which 44 (83.0%) had papillary, 4 (7.5%) 
follicular carcinoma, 4 (7.5%) medullary carcinoma and 1 (1.9%) had primitive thyroid 
paraganglioma (Costamagna et al., 2013). The study carried out by Miccoli et al. revealed 
that a 10.4% of patients operated for benign thyroid disease had incidental thyroid 
malignancy from the final histopathology report (Miccoli et al., 2006).  
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3.2.2 The association between thyroid cancer and large goiter  
There was no study to evaluate the association between thyroid cancer and large goiter 
(defined by weight). The study conducted in 2007 by McCoy to evaluate the accuracy of 
FNAC to diagnose malignancy in thyroid nodules ≥ 4cm revealed that 26% of these 
patients had thyroid malignancy from final pathology after surgery. The false negative rate 
of FNAC is high and thyroid nodules ≥ 4 cm should be considered for diagnostic 
lobectomy regardless of FNAC results (McCoy et al., 2007). Similar study was conducted 
in year 2009 which reported 13.5% of thyroid malignancy in patients with nodules ≥ 4cm. 
The false negative rate for FNAC was as high as 50% observed in this study (Pinchot et al., 
2009). 
3.2.3 Risk factors for thyroid malignancy 
Few studies had reported the different risk factors for thyroid malignancy. Most of the 
studies were conducted on MNG. Luo et al. conducted a study of 838 patients with MNG 
who underwent thyroidectomies and found that 31% of patients have thyroid malignancy 
from the final pathologic diagnosis. In this study, Luo et al. suggested that risk factors for 
malignancy in a MNG were male gender, younger age, fewer nodules, and smaller nodule 
size. Thyroid weight was not associated with the risk of malignancy (Luo et al., 2012). In 
year 2005, Rios et al. described in his study that the risk factors for thyroid cancer in MNG 
are family history of thyroid pathology, personal history of cervical radiation therapy, prior 
surgery, and presence of cervical adenopathies (Rios et al., 2004).  
 Based on the Korean National Health and Nutrition Examination Survey 2010-
2011, the association between the socioeconomic status and thyroid cancer were reviewed. 
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The study was population-based and it was for all type of thyroid malignancies regardless 
of the types of goiter. Multivariable analysis revealed that older age (OR 1.03; 95%CI 
1.00,1.05), female (OR 8.16; 95%CI 2.99,22.24), overweight (OR 1.04; 95%CI 1.01,1.06), 
higher monthly household income (OR 3.27; 95%CI 1.16,9.20) for medium-highest 
household income vs lowest household income; OR 3.30; 95%CI 1.16,9.34 for highest 
household income vs lowest household income), higher educational level (OR 2.74; 
95%CI 1.16,6.46 for 10-12 years vs < 7 years) and alcohol consumption (OR 1.89; 95%CI 
1.08,3.32) were significant risk factors for thyroid cancer (Choi et al., 2013). 
3.2.4 Thyroid malignancy in STN versus MNG 
The difference in the prevalence of thyroid cancer in thyroid glands with STN versus MNG 
remains uncertain. Most of the studies showed more prevalence of thyroid cancer in STN 
than MNG. A meta-analysis was performed to evaluate the comparative prevalence of 
thyroid cancer in STN and MNG. Fourteen studies were recruited in the study. It 
encompassed 23565 patients with MNG and 20723 patients with STN. MNGs were found 
to have a lower risk of thyroid cancer than STN with OR 0.8 (0.67,0.96) (Brito et al., 
2013).  
 Study comparing malignancy in a nonfunctioning STN and MNG reported that 
malignant involvement in cold nodules of MNG did not differ significantly from that found 
in STN. In this study, thyroid scans were performed for all the subjects. FNAC was 
performed for all cold nodules in 146 patients and thyroid cancers were confirmed by final 
pathology report after surgery. The rate of malignancy in cold nodules in the MNG group 
was 9.78%, in comparison with 8% in the group with STN (P = 0.89). It was concluded 
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that no significant difference in the prevalence of malignancy in cold nodules in MNG and 
STN (Sachmechi et al., 2000). Gandolfi et al. and Pradhan et al. both reported a significant 
percentage of thyroid cancer in MNG which was 13.7% and 13.6%, respectively (Gandolfi 
et al., 2004; Pradhan et al., 2011).  
3.2.5 Thyroid malignancy in toxic versus non-toxic goiter.  
A meta-analysis was performed comparing the incidence of thyroid cancer in patients who 
underwent surgery for toxic and nontoxic nodular goiter. Four studies were recruited in the 
meta-analysis with a total of 1,964 subjects undergoing thyroidectomy for benign thyroid 
diseases were analyzed. Among 1,964 subjects, 520 patients had toxic MNG or toxic 
adenoma and 1,444 had non-toxic MNG or STN. There was no significant differences in 
the risk of incidental thyroid cancer in patients with toxic MNG vs non-toxic MNG, toxic 
adenoma vs non-toxic STN, and toxic versus non-toxic nodular goiter (Negro et al., 2013). 
Smith et al. reported as high as 18.3% of overall incidence of thyroid cancer in patients 
operated for toxic nodular goiter. This study also revealed a significantly higher cancer rate 
in toxic MNG than toxic STN (21% vs. 4.5 %, P < 0.05) (Smith et al., 2013). 
 Study in endemic country revealed an almost similar finding which 10.1% of 
thyroid malignancy was found in patients with hyperthyroidism who underwent thyroid 
surgery. Occult papillary thyroid cancer was the most common type of malignancy found 
and accounted for 62.9% of all cancer diagnosed. The prevalence of carcinoma was 11.6% 
in toxic MNG, 7.7% in toxic STN, and 7.1% in patients with Graves' disease (Karagulle et 
al., 2009).  
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3.3 Pre-operative diagnosis of thyroid malignancy  
3.3.1 Ultrasonography  
Wharry et al. performed a study to determine the accuracy of pre-operative US in 
diagnosing thyroid malignancy for patients with nodule ≥ 4cm. There was 20% risk of 
malignancy in patients who had no suspicious US features pre-operatively. The author 
concluded that the absence of suspicious US features did not reliably exclude malignancy 
and proposed for surgery in patients with thyroid nodule ≥ 4cm (Wharry et al., 2013).  
 3.3.2 FNAC  
A retrospective study to determine the risk of malignancy in non-diagnostic US-guided 
FNAC in MNG was performed and showed that 12.6 % of patients had malignancy from 
post-operative pathology results. Risk of malignancy in non-diagnostic FNAC despite US-
guidance is still high and should be informed to the patient (Akgul et al., 2011).  
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3.4 Surgical complications in thyroidectomy   
A retrospective study in Greece regarding the surgical complications in 2,043 patients who 
underwent thyroid surgery between 1996 and 2007 indicated that transient RLN palsy 
occurred in 1.6% and permanent RLN palsy in 0.9% of patients. The rates of transient and 
permanent hypoparathyroidism were 27.8% and 4.8%, respectively. From this study, 
specimen weight was one of the independent predictor for transient hypocalcaemia but not 
permanent hypoparathyroidism following thyroidectomy with odd ratio of 1.6 (p=0.02). 
Other less common complications namely wound infection and hematoma occurred in 0.3% 
and 1.3% of patients, respectively (Karamanakos et al., 2010). 
 Study by Gardiner et al. regarding surgical complications for thyroidectomy 
published in year 1995, 64 (14%) out of a total of 474 patients underwent thyroidectomies 
had large MNGs ≥ 100g. There was no perioperative mortality. Complications included 
permanent unilateral vocal cord paralysis in two patients (3.1%), permanent 
hypoparathyroidism in two (3.1%) and temporary emergency tracheostomy in one 
individual (1.6%) (Gardiner and Russell, 1995). Recent literature regarding complications 
of thyroidectomy for large goiter revealed a higher rate of difficult intubation, 
tracheostomy, and longer hospital stay especially if the surgery was performed for huge 
goiters and malignant disease. This study compared the complication rate in patients with 
goiters ≤ 400g and > 400g. The post-operative complications namely hemorrhage, tracheal 
injury, oesophageal injury, temporary hypocalcemia, temporary hoarseness, permanent 
hypoparathyroidism, and permanent RLN palsy did not differ significantly between the 
two groups (Agarwal et al., 2012).  
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3.5 Indication for thyroid surgery  
According to AACE/AME/ETA Guidelines 2010, the indication for surgery in thyroid 
nodule are presence of local pressure symptoms, previous external irradiation, progressive 
nodule growth, suspicious US features, cosmetic issues and malignant disease (Gharib et 
al., 2010). It was mentioned in the latest American Thyroid Association statement on 
surgical management of goiter that the indications for thyroidectomy are present of 
symptoms related to compression, suspicion for malignancy, prevention of complication 
from progressive enlargement or mediastinal extension, and for cosmesis (Chen et al., 
2013). 
 There were only few literatures stated the issues regarding large goiter. The 
management of large goiter is suboptimum and none of the pre-operative investigation can 
accurately rule out malignancy. The associate risks for thyroid malignancy in large goiter 
are the important demographic and clinical features to suggest the likelihood of a patient 
with large goiter to harbor a malignancy and require a proper management. Furthermore, 
surgical complication for large goiter should be minimal and comparable to the surgical 
complication for small goiter.  
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CHAPTER 4: MATERIALS AND METHODS  
4.1 Study design and source population  
This was a cross-sectional study of patients who had undergone thyroidectomy in the 
Department of Breast and Endocrine Surgery, Hospital Raja Perempuan Zainab II (HRPZ 
II), Kelantan, Malaysia from January 2007 to May 2013. Recruitment of subjects was done 
based on the record of the list of patients who underwent thyroidectomy. The data of 
patients was retrieved from patients’ medical records.  
 
4.2 Eligible subjects  
All patients who fulfilled the inclusion and exclusion criteria were recruited  
Inclusion criteria: 
• All patients who have undergone thyroidectomy (total and hemithyroidectomy) during 
the duration of study.  
Exclusion criteria: 
• Patient underwent isthmectomy, subtotal and near total thyroidectomy. 
• Patient underwent completion thyroidectomy with prior history of surgery for thyroid 
cancer (only the first surgery was recruited). 
• Patient underwent excision of recurrent nodule with prior history of surgery for thyroid 
(only the first surgery was recruited).  
• Patient without thyroid enlargement who underwent total thyroidectomy for thyroid 
cancer which the diagnosis of thyroid cancer was made from the metastatic lesion.  
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Universal sampling method was applied to get the final study subjects. The patients 
with missing case notes or incomplete data were excluded from the study. Exclusion due to 
incomplete data only applied for important information such as weight of thyroid gland, 
variables involved in the analysis (age, sex, pressure symptoms, thyroid function status, 
nodularity), and histopathology result of resected specimen.  
 
4.3 Sample size   
Sample size estimation was calculated using single proportion formula for prevalence of 
large goiter (research question 1) and prevalence of malignancy in large goiter (research 
question 2). The calculation was to achieve a 95% confidence interval of absolute precision 
+/- 5% with 5% level of significant. 20% non-respondents was expected and added to 
achieve the final estimated sample size.  
 Estimated sample size for research questions number 3 and 4 which involved 2 
means or 2 proportions was calculated using Power and Sample Size Calculation software 
version 3.0.10. The power of study was set at 80% (1-β = 0.8) with the significance level 
of 5% (α = 0.05). Each associate factor for thyroid malignancy was calculated separately 
and 20% of non-respondents were included. The largest estimated sample size was taken as 
the target sample size needed for this study. Calculated sample size was 590 patients. The 
target sample size was achieved in this study and the total study subjects were 614. (See 
detail sample size calculation in Appendix A) 
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4.4 Research protocol  
The study protocol was reviewed and approved by the Human Research and Ethics 
Committee, School of Medical Sciences, Universiti Sains Malaysia (Appendix B) as well 
as the Medical Review and Ethics Committee (MREC), Ministry of Health Malaysia 
(Appendix C). A list of patients who underwent thyroidectomy from January 2007 through 
May 2013 was obtained from the record in the operation theater. Patients who fulfilled the 
inclusion and exclusion criteria were recruited in the study. Their medical records were 
reviewed retrospectively.   
 In HRPZ II, patients who indicated and agreed for surgery were scheduled for 
elective surgery. Occasionally, emergency thyroidectomies were performed for patients 
with obstructive goiter that required ventilation. For elective cases, a routine history taking 
and physical examination were performed to obtain basic demographic data, to assess the 
presence of pressure symptom, to check the status of thyroid function and to examine the 
thyroid enlargement. Biochemical test for thyroid function was taken for each patient 
routinely, and presence of hyperthyroidism or hypothyroidism was treated to ensure 
euthyroidism at the time of surgery. Pre-operative ultrasonography and FNAC were 
performed only for those who indicated. FNAC were performed without ultrasound-guided 
in HRPZ II. Computed Tomography scan (CT scan) were performed for patients with huge 
goiters or suspected substernal goiters. Indirect laryngoscopy was performed pre-
operatively for all patients to assess the vocal cords function.  
 The thyroid surgery was performed by either the endocrine surgeon or the trainee in 
endocrine surgery with supervision. The operation was performed by making a collar 
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incision two finger breadths above the sternal notch. Adrenaline was infiltrated before the 
skin incision. Superior and inferior subplatysmal flaps were raised from the thyroid 
cartilage to the sternal notch. The strap muscles were not routinely divided except for large 
goiter. The middle thyroid veins were ligated and divided if present. The superior thyroid 
vessels were individually ligated and divided. The RLN was identified and preserved. 
Inferior thyroid artery was ligated and divided. Identification of all parathyroid glands was 
preferred. Inadvertent parathyroid gland removal was followed by autotransplantation into 
the ipsilateral sternocleidomastoid muscle. Procedure was completed according to the 
extent of surgery.  
Weighing of resected thyroid gland was performed immediately after the removal 
from the neck before it was placed in the hypertonic Formalin to avoid drying from 
osmotic effect. Suction drain was routinely inserted and removed when the 24 hours 
drainage was < 30ml. Patients were monitored closely after the surgeries for any post-
operative complications. Routinely, serum calcium levels were checked at 6 hours post-
operatively and the day after the operation. Hypocalcaemia was treated with oral calcium 
supplementation with or without Vitamin D analogues. Intravenous administration of 
calcium gluconate was given for patients with obvious clinical symptoms and signs of 
hypocalcaemia. Post-operative follow up for patients was at one month initially and three 
monthly interval afterwards. Thyroid function test, serum calcium level and indirect 
laryngoscopy examination were only performed when indicated.  
  In this study, patients were divided into groups with large or small goiter according 
to the weight of the resected thyroid glands. The diagnosis of thyroid malignancy was 
made based on the final histopathological report. The proportion of large goiter and the 
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proportion of thyroid malignancy in large goiter were recorded. The associate factors for 
thyroid malignancy in large goiter were analyzed. The variables included in the study were 
age and sex of patients, presence of pressure symptoms, thyroid function status, and 
nodularity of the thyroid gland. The follow up for surgical complications was performed 
on the sixth month after the surgery for this study.   
 
4.5 Data collection   
Permission from the Director of HRPZ II for retrieving the patients’ medical 
records from record office was officially granted prior to the data collection activities. Data 
collected was recorded in a pre-formatted data collection form (Appendix D). The data 
recorded include patients’ demographic data (Age, sex and ethnics), pre-operative 
information (pressure symptoms, nodularity of goiter, thyroid function status and FNAC 
result), operative information (date and duration of procedure, indication for surgery, type 
of surgical procedure, seniority of the surgeon, the weight of resected specimen and intra-
operative surgical complication), post-operative surgical complication (temporary 
hypocalcaemia, permanent hypoparathyroidism, RLN palsy, haemorrhage, SSI, other 
organ injury and death), and final histopathological diagnosis after surgery. 
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4.6 Definition in the study   
4.6.1 Definition of large goiter 
Large goiter was defined by a resected specimen of more than or equal to 50g in 
hemithyroidectomy and more than or equal to 100g in total thyroidectomy. Total 
thyroidectomy was done by extracapsular dissection removing both of the thyroid lobes, 
isthmus and pyramidal lobe. Hemithyroidectomy was performed by removing unilateral 
thyroid lobe including the isthmus and pyramidal lobe.  
4.6.2 Pressure symptoms  
Pressure symptoms for goiter include discomfort, dysphagia, various degrees of difficulties 
in breathing and hoarseness of voice. Patients were categorized into 2 groups according to 
whether the pressure symptom was present or not without considering the type and 
duration of the symptoms.  
4.6.3 Nodularity of thyroid gland 
A goiter was classified into diffuse or nodular goiter. Nodular goiter was further classified 
into STN and MNG. MNG was defined as goiter with two or more nodules.  
4.6.4 Thyroid function status 
Patient with goiter may have different functional status. Definition of toxic goiter is 
determined by the laboratory thyroid function test (TFT) of elevated tri-iodothyronine (T3), 
elevated thyroxine (T4) and/ or suppressed thyroid stimulating hormone (TSH) or patient 
was on anti-thyroid medication before the surgery. Hypothyroidism was diagnosed by low 
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T3 and/ or T4 and/ or high TSH or patient was on thyroxine replacement. Euthyroid goiter 
included patient with normal TFT and without being treated with medication. 
4.6.5    Temporary hypocalcaemia and permanent hypoparathyroidism 
Temporary hypocalcaemia was considered when patient was symptomatic, corrected serum 
total calcium level was less than 2.0 mmol/l, requiring calcium and/or vitamin D 
supplements but with all symptoms resolved within 6 months post-operation. Permanent 
hypoparathyroidism was defined as hypocalcaemia that persists for more than 6 months 
and need regular calcium and vitamin D supplements. 
4.6.6 RLN palsy  
Temporary vocal cord dysfunction was not included in this study. Persistent hoarseness 
after six months post-operation was the indication to subject patient to indirect 
laryngoscopy examination by Ear, Nose and Throat (ENT) surgeon. Permanent RLN palsy 
was defined as presence of sustained immobility of the vocal cords six months after the 
surgery. Vocal cord palsy before the surgery was not counted as the surgical complication 
in this study.  
4.6.7 Haemorrhage and SSI 
Definition of haemorrhage ranged from acute bleeding intra-operatively, bleeding shortly 
after the surgery that needed emergency exploration to haematoma with or without surgical 
evacuation. Definition of SSI was according to the Centers for Disease Control & 
Prevention 1992 (Appendix E)(Horan et al., 1992).  
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4.7 Data analysis  
Data entry and analysis was done using Statistical Package for Social Science (SPSS) 
version 20.0. For descriptive analysis, categorical variables were expressed as frequencies 
(n) and proportions (%) while numerical variables were reported as mean with standard 
deviations (SD) or median with interquartile range (IqR). The prevalence of large goiter 
and prevalence of thyroid malignancy in large goiter were described as frequencies (n) and 
proportions (%) 
The association between large goiter and thyroid malignancy was examined by 
comparing the proportions with Chi-square test. The demographic (age, sex) and clinical 
(nodularity, pressure symptom, thyroid function status) variables were analyzed as the 
associate factors for thyroid malignancy in large goiter. In univariable analysis, 
independent variables were initially assessed individually using the Simple Logistic 
Regression to determine the significant of each variable in predicting its association with 
thyroid malignancy. Odds Ratio (OR) and respective 95% Confidence Intervals (CI) were 
calculated for all clinical parameters. In multivariable analysis, Multiple Logistic 
Regression was applied. Preliminary main effect model was created with Forward 
Likelihood Ratio (LR) on all the clinical important and significant variables. 
Multicollinearity and interaction were checked to obtain the preliminary final model. The 
final model was checked for fitness using the Hosmer-Lemesshow test, classification table 
to count for overall correctly classified percentage, and the Receiver Operating 
Characteristic (ROC) curve to check for the area under ROC curve. The adjusted Odds 
Ratio was obtained from the final model. The level of statistical significance was set at p < 
0.05.  
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4.8 Methodology Flow Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source population was identified.  
Patients underwent thyroidectomy in HRPZ II from June 2007 to May 2013 
(6 years duration). 
Cases were identified from the record in the operation theater.  
Exclusion criteria: 
• Patient underwent isthmectomy, subtotal or near total thyroidectomy 
• Patient underwent completion thyroidectomy, excision of recurrent 
nodule with prior history of surgery for thyroid cancer 
• Patient without thyroid enlargement who underwent total 
thyroidectomy for thyroid cancer which the diagnosis of thyroid 
cancer was made from metastatic lesion. 
Inclusion criteria: 
• All patients 
underwent total and 
hemithyroidectomy  
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